Molecular markers for cladistic analyses may perform differently according to the taxonomic group considered and the historical level under investigation. Here we evaluate the phylogenetic potential of five different markers for resolving evolutionary relationships within the ectoparasitic genus Dermanyssus at the species level, and their ability to address questions about the evolution of specialization. COI provided 9-18% divergence between species (up to 9% within species), 16S rRNA 10-16% (up to 4% within species), ITS1 and 2 2-9% (up to 1% within species) and Tropomyosin intron n 8-20% (up to 6% within species). EF-1alpha revealed different non-orthologous copies within individuals of Dermanyssus and Ornithonyssus. Tropomyosin intron n was shown containing consistent phylogenetic signal at the specific level within Dermanyssus and represents a promising marker for future prospects in phylogenetics of Acari. Phylogenetic analyses revealed that the generalist condition is apomorphic and D. gallinae might represent a complex of hybridized lineages. The split into hirsutus-group and gallinae-group in Dermanyssus does not seem to be appropriate based upon these results and D. longipes appears to be composed of two different entities.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2871134 | PMC |
| http://dx.doi.org/10.3390/ijms11041704 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Runx3, Brn3a and Isl1 interplay orchestrates the transcriptional program in the early stages of proprioceptive neuron development.
PLoS Genet
December 2024
Department of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel.
Article Synopsis
- The study investigates the role of transcription factors Runx3, Brn3a, and Isl1 in the development of sensory proprioceptive neurons, highlighting the serious impact of Runx3 deficiency on neuron survival and motor function.
- The researchers used RNA sequencing and genomic techniques to analyze the interactions and binding sites of these transcription factors in TrkC neurons.
- Their findings reveal that Runx3 primarily interacts with Brn3a to regulate target gene expression through enhancers, while it also plays a distinct role in suppressing immune-related genes.
Novel Compound Heterozygous Splice-Site Variants in TPM3 Revealed by RNA Sequencing in a Patient with an Unusual Form of Nemaline Myopathy: A Case Report.
J Neuromuscul Dis
September 2023
Folkhälsan Research Center, Helsinki, Finland.
Background: Pathogenic variants in the TPM3 gene, encoding slow skeletal muscle α-tropomyosin account for less than 5% of nemaline myopathy cases. Dominantly inherited or de novo missense variants in TPM3 are more common than recessive loss-of-function variants. The recessive variants reported to date seem to affect either the 5' or the 3' end of the skeletal muscle-specific TPM3 transcript.
View Article and Find Full Text PDFChina special issue on gastrointestinal tumors-NTRK fusion in a large real-world population and clinical utility of circulating tumor DNA genotyping to guide TRK inhibitor treatment.
Int J Cancer
December 2023
Department of Gastrointestinal Oncology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University Cancer Hospital and Institute, Beijing, China.
Neurotrophic tropomyosin receptor kinase (NTRK) gene fusions are rare oncogenic drivers and targets of TRK inhibitors in solid tumors. Little is known about NTRK fusion in Chinese patients with pan-cancer. Our study investigated the prevalence and genomic features of NTRK1/2/3 gene fusions in 67 883 Chinese patients with pan-cancer using next-generation sequencing (NGS) data and circulating tumor DNA (ctDNA) NGS to guide TRK inhibitor treatment and resistance monitoring.
View Article and Find Full Text PDFTranscript-Based Diagnosis and Expanded Phenotype of an Intronic Mutation in TPM3 Myopathy.
Mol Diagn Ther
September 2022
The Morris Kahn Laboratory of Human Genetics at the National Institute of Biotechnology in the Negev, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva, Israel.
Introduction: Congenital myopathies are a broad group of inborn muscle disorders caused by a multitude of genetic factors, often characterized by muscle atrophy and hypotonia.
Methods: Clinical studies, imaging, histology, whole-exome sequencing (WES) and muscle tissue RNA studies.
Results: We describe a severe congenital myopathy manifesting at birth with bilateral clubfeet, delayed motor development and hypotonia, becoming evident by 4 months of age.
SLM2 Is A Novel Cardiac Splicing Factor Involved in Heart Failure due to Dilated Cardiomyopathy.
Genomics Proteomics Bioinformatics
February 2022
Department of Cardiology, Angiology and Pneumology, University Hospital Heidelberg, D-69120 Heidelberg, Germany; German Center for Cardiovascular Research (DZHK), Partner site Heidelberg, D-69120 Heidelberg, Germany; Stanford Genome Technology Center, Department of Genetics, Stanford Medical School, Palo Alto, CA 94304, USA. Electronic address:
Alternative mRNA splicing is a fundamental process to increase the versatility of the genome. In humans, cardiac mRNA splicing is involved in the pathophysiology of heart failure. Mutations in the splicing factor RNA binding motif protein 20 (RBM20) cause severe forms of cardiomyopathy.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!